Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma

NCT00903461 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped drug supply issues

Conditions

Carcinoma, Squamous Cell of Head and Neck
Squamous Cell Carcinoma of the Head and Neck
Squamous Cell Carcinoma, Head And Neck

Interventions

BIOLOGICAL: EGFR Antisense DNA

Sponsor

University of Pittsburgh

Collaborators

[object Object]